Motor Neuroprosthesis (MNP)
DeviceType of implantable brain computer interface
NCT Number: NCT05035823
The Synchron motor neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility.
The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.
This study is active but is not currently recruiting participants.
21 year–75 year
All sexes
Interventional
Not applicable
University at Buffalo Neurosurgery (UBNS), Buffalo, New York, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Type of implantable brain computer interface
Time frame: 12 months post implant
Number of subjects with treatment-related adverse events
Synchron Medical, Inc.
Industry
Motor NeuroProsthesis to Restore Motor Control for the COMMAND of Digital Devices: An Early Feasibility Study (EFS) of Safety in Subjects With Severe Quadriparesis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04564495
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
White Plains, New York, United States
View Trial DetailsNCT07533903
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Melbourne, Australia
View Trial DetailsNCT05951985
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Fort Smith, Arkansas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial Details